NLRP3 and colorectal carcinoma: These data indicate that when considering patients with chronic colitis are more susceptible to developing CRC [4], curcumin can also be beneficial in terms of preventing tumorigenesis by inhibiting the NLRP3 inflammasome complex in macrophages at the inflammation site, and can hamper the inflammation.